World-class researchers from some of Australia’s best universities and hospitals come together at the Centre for Lung Cancer Research to form the Lung Cancer Research Network.
The Network, made up of over 20 research teams, forms a multidisciplinary group of basic and applied researchers and clinicians, with more to join as the centre expands.
At this one-of-a kind facility, researchers can share results and innovate faster, advancing the field of lung cancer diagnosis and treatment as has never been seen before.
Lung cancer is the 4th most common cancer in Australia and has the highest mortality rate. More than 10,000 cases of lung cancer are diagnosed in Australia annually and the disease kills more women than breast cancer. There is a stigma attached to lung cancer that is not associated with other cancers. This means that advances that have made in diagnosis and treatment of cancers such as breast and prostate has not happened in lung cancer. This world-first Lung Cancer Research Network addresses these issues and provides a path for the rapid discovery, development and implementation of innovative diagnosis and therapies for lung cancer sufferers.
The Lung Cancer Research Networks goal is to develop innovative solutions that will improve the healthcare outcomes and quality of life for people suffering with lung cancer. As part of this goal the Network has identified a number of streams or 'Core Translational Projects'. These projects leverage the large Network of basic scientists and healthcare professionals working in the area of lung cancer and are broadly split into early diagnosis, therapy, improving quality of life and improving clinical care. These projects are classified as translational since we will rapidly translate findings and new discoveries to the clinic, to make a positive impact for those diagnosed with lung cancer.
Core translational projects:
The Network’s founding research teams have a proven track record in research and clinical excellence.
With this experience and reach, they’re perfectly placed to engage with patients, funders and industry and fuel desperately-needed growth in lung cancer research.
The Network links researchers with clinicians and health care providers across five core areas: patient interface, mechanism of disease, drug discovery, modelling disease/drug evaluation, and drug delivery and technology.
This unique approach allows for a truly translational path to treating lung cancer, since each arm can provide scientific input, material and knowledge that support research in the other arms.
Excitingly, this collaborative environment allows for an almost unlimited number of ‘multi- disciplinary’ projects.